β¨ Medicine Distribution Notices
1628
NEW ZEALAND GAZETTE, No. 67
14 APRIL 2005
Product: Glivec
Active Ingredient: Imatinib mesilate 478mg (equivalent to imatinib base 400mg)
Dosage Form: Film-coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 8th day of April 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2232
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new medicines set out in the Schedule hereto:
Schedule
Product: Kivexa
Active Ingredients: Abacavir sulphate 702mg (equivalent to abacavir 600mg)
Lamivudine 300mg
Dosage Form: Film-coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Glaxo Operations UK Limited, Ware, Hertfordshire, United Kingdom
Product: Paracetamol
Active Ingredient: Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: IPCA Laboratories Limited, Athal, Silvassa, Dadra and Nagar Haveli (U T), India
Dated this 8th day of April 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2235
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set
out in the Schedule hereto:
Schedule
Product: Zyvox
Active Ingredient: Linezolid 20mg/mL
Dosage Form: Granules for oral suspension
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Arecibo, Puerto Rico
Product: Zyvox
Active Ingredient: Linezolid 2mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Fresenius Kabi Norge AS, Berg I Ostfold, Halden, Norway
Product: Zyvox
Active Ingredient: Linezolid 400mg
Dosage Form: Film-coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Arecibo, Puerto Rico
Product: Zyvox
Active Ingredient: Linezolid 600mg
Dosage Form: Film-coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Pharmaceuticals LLC, Arecibo, Puerto Rico
Dated this 8th day of April 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2233
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 67
Gazette.govt.nz —
NZ Gazette 2005, No 67
β¨ LLM interpretation of page content
π₯
Provisional Consent for Distribution of New Medicine
(continued from previous page)
π₯ Health & Social Welfare8 April 2005
Medicines Act 1981, Provisional Consent, Glivec, Imatinib mesilate
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare8 April 2005
Medicines Act 1981, New Medicines, Kivexa, Paracetamol
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to the Distribution of a Changed Medicine
π₯ Health & Social Welfare8 April 2005
Medicines Act 1981, Changed Medicine, Zyvox, Linezolid
- DON MATHESON, Deputy Director-General, Public Health